Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

FDA clears generic estradiol product

Oct. 29, 1997

Shaman issued U.S. patent for antidiabetic compounds

Oct. 28, 1997

Watson acquires Searle contraceptive products

Oct. 27, 1997

New antidiabetic agents from Boehringer Mannheim

Oct. 24, 1997

Major advance in thalassemia research reported

Oct. 24, 1997

Lower dose version of Caverject introduced

Oct. 23, 1997

Viagra awarded priority review status by FDA

Oct. 23, 1997

Role of angiotensin II in erectile function investigated

Oct. 23, 1997

Trazodone evaluated in patients with erectile dysfunction

Oct. 23, 1997

rhIGF-1 improves lipid profiles in adults with IDDM

Oct. 23, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...